当前位置:首页 > 报告详情

开心生活科技:欧美市场准入模式概况和发展趋势(2022)(14页).pdf

上传人: 新** 编号:128799 2023-06-12 14页 9.87MB

下载:

1、?Market?Access?in?US?and?EU?An?Overview杨眉(Mei Yang)Ph.D.VP of iHS Global,开心生活科技(Happy Life Tech)2Content?What is market access!#$%&!#$%&03HTAs in Europe Countries()*+,-./012()*+,-./0120402US payers&ICER 3*4563*456789:;789:;01Future of market access$%&,=$%&,=Economic?Evaluation?in?Drug?Development?an

2、d?Market?Access?LicensingPricing/ReinbursementMarket AccessEvidenceQualitySafetyEfficacyCost-effectivenessTHERE WAS GENERAL AGREEMENT THAT THE FORTH HURDLE WAS THE ONE TO LOOK OUT FORSource:Cai J.Real World Evidence&Market Access Summit 2015Forth Hurdle!#$%$%&$&$()()*+,-*+,-./01./0123234 4565617/817

3、/8What?is?Market?Access?Definition!Market access is about getting the right treatment to the right patient at theright time,and at the right price.#$%&()*+,-#$%&()*+,-./)0+1/)0+122.34)56+789:*;+?34)56+789:*;+?AB%AB%CD!1CD!1E EFGFGHIJKLMNOHIJKLMNOPQR78STPQR78ST+UV!+UV!Communicating value to healthcar

4、e stakeholdersOverview?of?America?s?Multi-Payer?Landscape?Health care in the United States is currently a unique,hybrid,multiple-payer system.!#$%&()*+,-./0%123%14567%*+8!#$%&()*+,-./0%123%14567%*+8Public Payers 9:5679:567 Medicare(14.2%)Medicaid(19.8%)Military(1.4%)Private Insurers;Employer-Sponsor

5、ed(49.6%)Fully Insured or Self InsuredIndividual Market.?.?Non-Group(5.9%)Uninsured(9.2%)Public-Private Programs9;3A!9;3A!Medicare Advantage Medicaid Managed CareState and Federal Exchanges BCDEFGBCDEFG Affordable Care Act HealthInsurance MarketplaceSource:1.https:/nam.edu/health-care-payers-covid-1

6、9-impact-assessment-lessons-learned-and-compelling-needs/US?Prescription?Drug?Spending?Spending by private health insurance,Medicare,and Medicaid accounts for more than 80%of total retail prescription drug spending in the US in 2017.!#$%#$%&()*+,-.&()*+,-./0123450/012345066/0123421/0123421789:;?AB78

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文主要探讨了美国和欧盟市场的准入问题,以及药品市场准入中的关键因素。文章指出,市场准入是确保药品以合适的时间、地点和价格到达患者的正确治疗。美国是一个独特的混合支付系统,包括公共支付者和私人支付者。公共支付者如 Medicare 和 Medicaid,私人支付者如雇主赞助的保险和个体市场。ICER( Institute for Clinical and Economic Review)在美国药品市场准入中扮演越来越重要的角色,通过对治疗效果的评估,为支付者与制造商之间的谈判提供价值基础价格标杆。文章还提到了欧洲市场准入的未来趋势,包括改革国家报销和定价流程、早期访问途径、更广泛地采用真实世界证据(RWE)、增加对仿制药和生物类似物的支持以及增加跨境合作的意图。
有何不同?" 如何影响药品定价?" 制药企业如何应对挑战与机遇?"
客服
商务合作
小程序
服务号
折叠